Davenport C, Liew A, Doherty B, et al. The prevalence of adrenal incidentaloma in routine clinical practice. Endocrine 2011;40(1): 80–83.
Ignaszak-Szczepaniak M, W awrzyniak A, Celczyńska-Bajew, i wsp. Przypadkowo wykryty guz nadnercza jako problem diagnostyczny i terapeutyczny. Fam Med Prim Care Rev 2006; 8: 622–624.
Terzolo M, Pia A, Ali A, et al. Adrenal incidentaloma: a new cause of the metabolic syndrome? Clin Endocrinol Metab 2002;87: 998–1003.
Peppa M, Boutati E, Koliaki C, et al. Insulin resistance and metabolic syndrome in patients with nonfunctioning adrenal incidentalomas:a cause-effect relationship? Metabolism 2010; 59: 1435–1441. doi: 10.1016/j.metabol.2010.01.007.
Peppa M, Koliaki C, Raptis SA . Adrenal incidentalomas and cardiometabolic morbidity: an emerging association with serious clinical implications. J Intern Med 2010; 268(6): 555–566. doi: 10.1111/j.1365-2796.2010.02291.
Yener S, Ertilav S, Secil M, et al. Increased risk of unfavorable metabolic outcome during short-term follow-up in subjects with nonfunctioning adrenal adenomas. Med Princ Pract 2012; 21: 429–434. doi: 10.1159/000336589.
Kolańska K, Owecki M, Nikisch E, et al. High prevalence of obesity in patients with non-functioning adrenal incidentalomas.Neuro Endocrinol Lett 2010; 31: 418–422.